VLP Vaccine Production in Yeast

• Revolutionary VLP Vaccine Manufacturing Processes in Yeas

  The use of yeast to make VLP vaccines is a revolutionary leap in vaccine technology. Vaccines are usually developed by growing many copies of the virus in a lab, and then neutralizing it so that humans can take it upstream. The process could take very long time and it can be costly as well, because a lot of materials are needed for the mixture preparation in order to not damage them.

• Advancements in Vaccine Technology

  Yeast-based VLP vaccines speak for themselves — we do not need to use live viruses, which is safer for the people who are creating these vaccines. This also serves as a cost-effective solution. Yeast makes VLPs that resemble viruses and in doing so can help our bodies to defend against them. Our immune systems can therefore identify some real viruses and get ready to attack them if we ever come into contact with any.

• Improving Vaccine Access with Yeast-Produced VLP Vaccines

  For example, one of these novel ideas is the messenger RNA (mRNA) vaccines. The vaccines leverage instructions that are unique and they instruct our bodies how to generate a required protein which further assists the immune system in warding off infections. VLPs can also be produced using plants and insects, which has paved the way for novel strategies to achieve efficient vaccines.

Why choose Yaohai VLP Vaccine Production in Yeast?

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates quality management and regulatory issues. We have developed a solid quality management system that conforms to the current GMP standards and regulations globally. Our regulatory team has an in-depth understanding of the world-wide regulatory frameworks. This allows us to accelerate biological launches. We ensure traceable production processes as well as high-quality products and in compliance with the guidelines of the US FDA and EU EMA. VLP Vaccine Production in Yeast and China NMPA are also satisfied. Yaohai BioPharma successfully passed an on-site audit conducted by an accredited Qualified Person of the European Union (QP) to review our GMP system and production facility. We have also been through the first certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma is experienced in biologicals derived from microbial sources. We provide customized RD solutions and manufacturing, while minimising potential risks. We have worked on various modalities, including recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies enzymes, plasmid DNA various mRNAs, and more. We have specialized in multiple microorganisms, including VLP Vaccine Production in Yeast intracellular and extracellular secretion (yields up to 15g/L) and intracellular soluble bacteria and inclusion body (yields up to 10g/L). We have also established a BSL-2 fermentation platform to create bacteria-based vaccines. We are experts in improving processes, boosting product yields, and decreasing production costs. We have a highly efficient technology team that ensures timely and top-quality project delivery. This allows us to bring your unique products faster to market.

• Robust Supply Chain & Manufacturing Capabilities

  VLP Vaccine Production in Yeast is a Top 10 biotech company specializing in microbiological fermentation. We have built a modern facility with strong RD capabilities and modern manufacturing facilities. Five production lines for pharmaceuticals in line with GMP standards for microbial purification and fermentation along with two automated fill and finish lines for vials and cartridges and pre-filled needles are available. The fermentation scales available are 100L, 500L, 1000L, to 2000L. Specifications for filling vials range from 1ml up to 25ml. the pre-filled syringes and cartridge filling specifications cover between 1-3ml. The workshop for production is cGMP compliant, and guarantees a stable supply of commercial products and clinical samples. Our factory produces large molecules that are shipped around the world.

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading in VLP Vaccine Production in Yeast CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to treat pets, human and veterinary health. We possess cutting-edge RD and manufacturing technology platforms that cover the entire manufacturing process from the engineering of microbial strains, to cell banking processing and method design to clinical and commercial manufacturing, making sure that we can ensure the successful delivery of the most advanced solutions. We have accumulated a huge quantity of knowledge in the bio processing microbial field. More than 200 projects have been successfully completed and we help our clients comply with regulations like those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services due to our experience and expertise.

Related product categories

Not finding what you're looking for?
Contact our consultants for more available products.